Genetic analysis of adult-onset autoimmune diabetes

Diabetes

Volumn 60, Issue 10, 2011, Pages 2645-2653

  Howson, Joanna M M ^a   Rosinger, Silke ^b   Smyth, Deborah J ^a   Boehm, Bernhard O ^b   Aldinger, G ^c   Aufschild, J ^c   Bechtold, J ^c   Becker, G ^c   Beischer, W ^c   Bickel, R ^c   Blagieva, R ^c   Boehm, B O ^c   Bruckel J ^c   Claudi Boehm, S ^c   Dapp, A ^c   Eiermann, T ^c   Ermerling, R ^c   Gloyer, J ^c   Haak, T ^c   Haenle, M ^c   Hecker, W ^c   Holl, R ^c   Holland, A ^c   Hopfer S ^c   Jung, S ^c   Junginger, W ^c   Jutting G ^c   Kaser T ^c   Kieferle, J ^c   Koenig, W ^c   Kratzer, W ^c   Kristen, P ^c   Kuhnl P ^c   Kurkhaus, A ^c   Limberg, G ^c   Lippmann Grob, B ^c   Lobmann, R ^c   Maas, U ^c   Manfras, B ^c   Merger, S ^c   Muller K A ^c   Nikolaus, T ^c   Offensperger, W B ^c   Renner, H ^c   Rosak, C ^c   Rosinger, S ^c   Schilling, S ^c   Schreiber, G H ^c   Schuler, A ^c   Schwinn, G J ^c   Siegel, E ^c   Sing, R ^c   Spohr, E ^c   Standop, M ^c   Trischler, G ^c   Weickert, U ^c   Wildemann Gilbert, G ^c   Worner D ^c   Todd, John A ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; GLUTAMATE DECARBOXYLASE AUTOANTIBODY; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INSULIN; INSULINOMA ASSOCIATED ANTIGEN 2 AUTOANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; MEMBRANE PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PANCREAS ISLET CELL ANTIBODY; PROTEIN CLEC16A; PROTEIN FCRL3; PROTEIN FTO; PROTEIN SH2B3; STAT4 PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DIABETES; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 80053415774     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0364     Document Type: Article

References (41)

1. Barrett JC, Clayton DG, Concannon P, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-707
2. Leslie RD. Predicting adult-onset autoimmune diabetes: clarity from complexity. Diabetes 2010;59:330-331
3. Rolandsson O, Palmer JP. Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes! Diabetologia 2010;53:1250-1253
4. Steck AK, Eisenbarth GS. Genetic similarities between latent autoimmune diabetes and type 1 and type 2 diabetes. Diabetes 2008;57:1160-1162
5. Caillat-Zucman S, Garchon HJ, Timsit J, et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992;90:2242-2250 (Pubitemid 23010038)
6. Desai M, Zeggini E, Horton VA, et al. An association analysis of the HLA gene region in latent autoimmune diabetes in adults. Diabetologia 2007;50: 68-73 (Pubitemid 46035855)
7. Horton V, Stratton I, Bottazzo GF, et al.; UK Prospective Diabetes Study (UKPDS) Group. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). Diabetologia 1999;42:608-616 (Pubitemid 29196013)
8. Clayton DG. Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet 2009;5:e1000540
9. Todd JA. Etiology of type 1 diabetes. Immunity 2010;32:457-467
10. Desai M, Zeggini E, Horton VA, et al. The variable number of tandem repeats upstream of the insulin gene is a susceptibility locus for latent autoimmune diabetes in adults. Diabetes 2006;55:1890-1894 (Pubitemid 44324149)
11. Durinovic-Belló I, Wu RP, Gersuk VH, Sanda S, Shilling HG, Nepom GT. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes Immun 2010;11:188-193
12. Howson JM, Dunger DB, Nutland S, Stevens H, Wicker LS, Todd JA. A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 2007; 50:741-746 (Pubitemid 46355837)
13. Plagnol V, Howson JMM, Smyth DJ, et al. Genetic analysis of autoantibody positivity in Graves' disease and type 1 diabetes. PLoS Genet 2011;7:e1002216
14. Pettersen E, Skorpen F, Kvaløy K, Midthjell K, Grill V. Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trøndelag Health Study. Diabetes 2010;59:302-310
15. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-589
16. Kochi Y, Yamada R, Suzuki A, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005;37:478-485 (Pubitemid 40617275)
17. Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 2007;92:1106-1111 (Pubitemid 46465689)
18. Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab 2006;91:1056-1061 (Pubitemid 43357780)
19. Burton PR, Clayton DG, Cardon LR, et al.; Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium (TASC); Biologics in RA Genetics and Genomics Study Syndicate (BRAGGS) Steering Committee; Breast Cancer Susceptibility Collaboration (UK). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329-1337
20. Boehm BO, Manfras B, Seissler J, et al. Epidemiology and immunogenetic background of islet cell antibody-positive nondiabetic schoolchildren: Ulm-Frankfurt population study. Diabetes 1991;40:1435-1439
21. 125I-labelled recombinant GAD65 produced in yeast. Clin Chim Acta 1996;256:175-188
22. Endl J, Rosinger S, Schwarz B, et al. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes. Diabetes 2006;55:50-60 (Pubitemid 43343298)
23. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678
24. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006;38:209-213 (Pubitemid 43177235)
25. Dendrou CA, Plagnol V, Fung E, et al. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet 2009;41:1011-1015
26. Saxena R, Gianniny L, Burtt NP, et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006;55:2890-2895 (Pubitemid 44923692)
27. Bakhtadze E, Cervin C, Lindholm E, et al. Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients. Diabetologia 2008;51:2224-2232
28. Raj SM, Howson JMM, Walker NM, et al. No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia 2009;52:2109-2116
29. Long SA, Cerosaletti K, Wan JY, Ho JC, Tatum M, Wei S, et al. An autoimmune- associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells. Genes Immun 2011;12:116-125
30. Maue AC, Yager EJ, Swain SL, Woodland DL, Blackman MA, Haynes L. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol 2009;30:301-305
31. Yamanouchi J, Rainbow D, Serra P, et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007;39:329-337 (Pubitemid 46328484)
32. Long SA, Cerosaletti K, Bollyky PL, et al. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+) CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes 2010;59: 407-415
33. Howson JMM, Stevens H, Smyth DJ, et al. Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes 2011;60:2635-2644
34. vandewalle CL, Falorni A, Lernmark A, et al. Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry. Diabetes Care 1997;20: 1547-1552 (Pubitemid 27415032)
35. Duchatelet S, Caillat-Zucman S, Dubois-Laforgue D, Blanc H, Timsit J, Julier C. FCRL3 -169CT functional polymorphism in type 1 diabetes and autoimmunity traits. Biomed Pharmacother 2008;62:153-157 (Pubitemid 351381936)
36. Turunen JA, Wessman M, Kilpikari R, Parkkonen M, Forsblom C, Groop PH; FinnDiane Study Group. The functional variant -169C/T in the FCRL3 gene does not increase susceptibility to type 1 diabetes. Diabet Med 2006; 23:925-927 (Pubitemid 44141085)
37. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-2033
38. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359:2767-2777
39. Fung EY, Smyth DJ, Howson JM, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun 2009;10:188-191
40. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-323
41. Zeggini E, Weedon MN, Lindgren CM, et al.; Wellcome Trust Case Control Consortium (WTCCC). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007;316: 1336-1341 (Pubitemid 46871654)